Sobolewski P
Kliniki Okulistycznej AM, Białymstoku.
Klin Oczna. 1992;94(2-3):57-8.
The study presents the evaluation of treatment by Cronassial of 26 patients including 16 with post-inflammatory optic atrophy, 4 with optic neuritis and 6 multiple sclerosis patients with optic neuropathy. One half of the patients showed an improvement of the visual acuity and visual field, and small improvement of the visual evoked potentials. No improvement of the conductivity of the impulses of the retino-cortical potentials has been observed. The best efficacy of the compound has been seen in the inflammatory conditions of the optic nerve.
该研究展示了对26例患者使用克诺沙尔（Cronassial）进行治疗的评估，其中包括16例炎症后视神经萎缩患者、4例视神经炎患者和6例患有视神经病变的多发性硬化症患者。一半的患者视力和视野有所改善，视觉诱发电位有小幅改善。未观察到视网膜皮质电位冲动传导性的改善。该化合物在视神经炎症性疾病中显示出最佳疗效。
